Table 4.
Diabetes-related outcome measures at baseline and follow-up per participant.
| Measures | P1-ia | P2-ia | P3-ia | P4-ia | P5-ia | P6-ia | P7-cb | P8-cb | |
| CGMc adherence (%) | |||||||||
| 3 months | —d | 61 | 89 | 10 | 62 | 12 | 89 | 94 | |
| Glycemic control (HbA1c%) | |||||||||
| Baseline | 11.6 | >14 | 12.3 | 10.2 | 8.5 | >14 | 8.7 | 10.7 | |
| Follow-up | 9.8 | >14 | 9.8 | 9 | 8.4 | >14 | 9.3 | 9.5 | |
| CGM satisfaction survey score (max score 5) | |||||||||
| Baseline | 4.7 | 1.3 | 3.8 | 3.6 | 4.3 | 3.5 | 3.9 | 4.2 | |
| Follow-up | 3.9 | 4.0 | 3.9 | 3.8 | 4.3 | 3.6 | 3.9 | 3.9 | |
| CGM self-efficacy survey score (max score 100) | |||||||||
| Baseline | 100 | 100 | 94 | 83 | 97 | 68 | 93 | 96 | |
| Follow-up | 89 | 84 | 92 | 78 | 99 | 50 | 98 | 84 | |
| CGM knowledge assessment score (max score 100) | |||||||||
| Baseline | 40 | 65 | 80 | 65 | 70 | 40 | 60 | 85 | |
| Follow-up | 55 | 80 | 65 | 60 | 55 | 45 | 70 | 85 | |
aParticipant in the intervention group.
bParticipant in the enhanced standard care group.
cCGM: continuous glucose monitor.
dNot available.